EssiLux sues M&A target GrandVision to get COVID information
MILAN, July 18 (Reuters) - EssilorLuxottica ESLX.PA has filed a legal action to obtain information from its acquisition target GrandVision GVNV.AS about its management of the coronavirus crisis, the French-Italian maker of Ray-Ban said on Saturday.
EssilorLuxottica announced a 7.2-billion-euro bid for GrandVision in July last year, aiming to control the Dutch eyewear group's more than 7,000 outlets across the world.
It filed the legal proceedings before a district court in Rotterdam, the Netherlands, after GrandVision did not respond to its requests for information on its handling of the pandemic, EssilorLuxottica said in a statement.
"This is to assess the way GrandVision has managed the course of its business during the COVID-19 crisis, as well as the extent to which GrandVision has breached its obligations under the support agreement," EssilorLuxottica said, referring to the M&A agreement.
"Despite repeated requests, GrandVision has not provided this information on a voluntary basis, leaving EssilorLuxottica with no other option but to resort to legal proceedings," it added, without elaborating.
Earlier this week EU antitrust authorities extended their investigation on the deal to Aug. 27.
The coronavirus pandemic has caused setbacks to M&A transactions in recent months, in some cases triggering requests from prospective buyers to amend agreed terms.
Sources have told Reuters that LVMH Chief Executive Bernard Arnault has been exploring ways to potentially pressure M&A target Tiffany TIF.N to lower the agreed price of $135 per share for their planned deal.
EssilorLuxottica, formed last year from the merger of French lens maker Essilor and Italian eyewear group Luxottica, also owns the Oakley and Persol brands and Varilux lenses.
(Reporting by Francesca Landini, editing by Clelia Oziel)
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.